ONCOtherapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9201 W Sunset Blvd Ste 317, West Hollywo...Phone Number
(310) 623-1200Website
www.oncotherapeutics.comRevenue
<$5 MillionIndustry
About ONCOtherapeutics
ONCOtherapeutics Org Chart
Is ONCOtherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ONCOtherapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if ONCOtherapeutics has recently received funding, and reach out quickly before it becomes old news!
ONCOtherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ONCOtherapeutics launches new products
Funding: Get notified immidiatlly once ONCOtherapeutics has new funding data
Click to see if ONCOtherapeutics had a recent Job posting/layoffs
Check out if ONCOtherapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ONCOtherapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined ONCOtherapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to ONCOtherapeutics
Compare insights from companies similar to ONCOtherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ONCOtherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ONCOtherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ONCOtherapeutics.
ONCOtherapeutics financials insights
Gather financial insights about ONCOtherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$150K
ONCOtherapeutics Tech Stack
A closer look at the technologies used by ONCOtherapeutics
ONCOtherapeutics News & Media
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM). Results from the I-RUX Study Published in ASH2020
WEST HOLLYWOOD, Calif., Jan. 20, 2021 /PRNewswire/ -- ONCOtherapeutics and Dr. James Berenson published promising new data demonstrating that ruxolitinib (RUX), an oral JAK1/2 inhibitor, with only steroids is well tolerated and shows promising efficacy for treating heavily previously...New Technology Brings EHR Data to the Forefront of Clinical Research
Two innovative technology companies are leading the way to make EHR systems a more accessible tool in the clinical research industry. (PRWeb December 04, 2017) Read the full story at http://www.prweb.com/releases/2017/12/prweb14973513.htm
Top Business Services Companies
Frequently Asked Questions Regarding ONCOtherapeutics
ONCOtherapeutics is a strategic Contract Research Organization (CRO) specializing in community-based Hematology and Oncology research across the US. With over 15 years of experience, they focus on improving cancer therapies through clinical trials and real-world data. Their services cater to industry partners, clinical research sites, and patients,... Read More